The rise and fall of β-agonists in the treatment of ARDS.
about
The effects of salbutamol on epithelial ion channels depend on the etiology of acute respiratory distress syndrome but not the route of administration.TIP peptide inhalation in experimental acute lung injury: effect of repetitive dosage and different synthetic variants.Agonist binding to β-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair.Pre-hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC-2): Trial protocol.The beta agonist lung injury trial prevention. A randomized controlled trial.Albuterol in the treatment of acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
P2860
The rise and fall of β-agonists in the treatment of ARDS.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The rise and fall of β-agonists in the treatment of ARDS.
@en
type
label
The rise and fall of β-agonists in the treatment of ARDS.
@en
prefLabel
The rise and fall of β-agonists in the treatment of ARDS.
@en
P2093
P2860
P356
P1433
P1476
The rise and fall of β-agonists in the treatment of ARDS.
@en
P2093
Christopher R Bassford
David R Thickett
Gavin D Perkins
P2860
P2888
P356
10.1186/CC11221
P577
2012-12-12T00:00:00Z
P5875
P6179
1025883810